Table 1.

Ovarian cancer: priorities in outpatient visits and staging

High priority	Medium priority	Low priority
Outpatient visits
Potentially unstable (acute abdominal pain, intestinal obstruction, complications during postsurgery recovery. Symptomatic new patient (symptomatic ascites or pleural effusion, intestinal obstruction).	Newly diagnosed asymptomatic patients, no prior surgery. Postoperative patients with no complications. Patients continuing on ChT (telemedicine where possible). Established patients with new problems or symptoms from treatment (convert as many visits as possible to telemedicine appointments).	Follow-up visit on PARPi maintenance; most can be managed through telemedicine with blood tests and imaging done close to home. Explore postal drug delivery. Maintenance bevacizumab: if facilities exist to continue, supervision can be performed by telemedicine, ensuring BP and urinalysis are monitored. Survivorship visits off study.
Imaging
Symptomatic patient (intestinal obstruction, abdominal perforation).	Diagnostic imaging for clinical suspicion of ovarian cancer (clinical, US).	Follow-up visit out of study.* Follow-up visit on PARPi maintenance.

*For patients on clinical trials, seek information about changes in management for individual studies from the coordinating trials unit for treatment frequency, blood investigations and imaging.

BP, blood pressure; ChT, chemotherapy; PARPi, poly-ADP ribose polymerase inhibitors; US, ultrasound.